Quarterly ResultMay 7, 2026, 04:54 PM
SIGA Q1 Total Revenue Down 11.3% to $6.24M; Net Loss Widens to $3.45M
AI Summary
SIGA Technologies reported a decrease in total revenue for Q1 2026, down 11.3% to $6.24 million, primarily due to lower product sales. The company's net loss widened to $3.45 million from $0.41 million in the prior year. Despite the financial decline, SIGA declared a special cash dividend of $0.60 per share and entered a new exclusive license and distribution agreement with Hikma MENA FZE for oral TPOXX®.
Key Highlights
- Total revenues decreased 11.3% to $6.24 million in Q1 2026 from $7.04 million in Q1 2025.
- Net loss widened to $3.45 million ($0.05 per share) in Q1 2026 from $0.41 million ($0.01 per share) in Q1 2025.
- Product sales and supportive services revenue fell 39.2% to $3.54 million.
- Research and development revenue increased 121.8% to $2.70 million.
- Net cash used in operating activities was $8.66 million, compared to $7.06 million provided in Q1 2025.
- Declared a special cash dividend of $0.60 per share on March 26, 2026.
- Signed an exclusive license and distribution agreement with Hikma MENA FZE for oral TPOXX® in the MENA region.
- Cash and cash equivalents decreased to $145.56 million from $154.97 million at year-end 2025.